Publications

Notable and Original

Dr Kiprov and his colleagues have successfully translated the rejuvinative effect of parabiosis and plasma exchange observed in mice into a successful human model.

Kiprov, D, “Intermittent Heterochronic Plasma Exchange as a Modality for Delaying Cellular Senescence – A Hypothesis.” J Clin Apheresis 28:387-389 (2013)

Dr. Kiprov is the Medical Director of the clinical trial and a co-author of an article documenting the first scientifically proven treatment for Alzheimer's disease.

Boada M, Lopez O, Nunez L, Olazaran J, Pfeffer M, Paricio M, Lorites J, Pinol G, Gamez J, Anaya F, Ortiz P, Kiprov D, Grifols C, Torres M, Costa M, Bozzo J, Szczepiorkowski Z, Hendrix, S, Paez A. A Randomized Controlled Clinical Trial of Plasma Exchange with Albumin replacement for Alzheimer’s Disease: Primary Results of the AMBAR Study. Alzheimer’s and Dementia: June 4, 2020 DOI:10.1002/alz:12137

Dr. Kiprov is involved in the prevention and management of the corona virus disease (COVID-19).

Kiprov, D., Conboy, M. J. & Conboy, I. M. Immunomodulation for the management of corona virus disease (COVID-19). Transfus. Apher. Sci. 59, 102856 (2020).

Description of previously unrecognized syndrome of the prevalence of Focal Segmental Glomeruloscelerosis (FSG) in people born with a single kidney. This also sheds light on the pathogenesis of FSG.

Kiprov D, Clovin R, McCluskey R. Focal and segmental glomerulosclerosis and proteinura associated with unilateral renal agenesis. Lab Invest 46:275, 1982.

The first recognition that plasmapheresis affects not only the humoral but also the cellular immune system.

Kiprov D, Morand P. The effect of plasmapheresis and immunosuppressive drug therapy on T-cell subsets as defined by monoclonal antibodies. J Clin Aphere 1-57, 1983.

The first recognition of distinctive anti-lymphocyte factors in sera form patients with HIV infection.

Kiprov D, Anderson RE, Morand P, Simpson D, Chermann JC, Levy J, Moss A. Antilymphocyte antibodies and seropositivity for retroviruses in high risk groups for AIDS. N Engl Med 312:1517, 1985

Kiprov D, Morand P. Lymphocyte subpopulations and mitogenic response studies in homosexuals with acquired immunodeficiency syndrome. Immunobiology 163:377, 1982.

The first publication of a new immunologically-mediated syndrome affecting striated muscles.

Kiprov D, Miller R. Polymyositis associated with benign monoclonal gammopathy. Lancet II: 1183-1186, 1984.

Performed the first treatment (in humans) with the Prosorba immunoadsorption column (which subsequently was approved by the FDA).

Kiprov D, Lippert R, Jones RF, et al. Extracorporeal perfusion of plasma over immobilized Protein A in a patient with Kaposi’s Sarcoma and acquired immunodeficiency. J Biol Response Modifers 3:330-346, 1985

The first description of an auto-immune neurologic syndrome in patients with predisposition for AIDS (today this will be HIV positive). Subsequent publications document the pathogenesis of the new syndrome and propose effective therapy- the novel use of the combination – plasmapheresis with IVIG.

Lipkin I, Parry G, Kiprov D, et al. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology 35:1479-1483, 1985.

Kiprov D, Pfaell W, Parry G, Lang W, Miller R. Antibody-mediated peripheral neuropathies associated with ARC and AIDS: Successful treatment with plasmapheresis. J Clin Aphere 4:3-7, 1988. Miller R, Parry G, Lang W, Lippert R, Kiprov D. AIDS-related inflammatory Polyradiculoneuropathy: Successful treatment with plasma exchange. Neurol 36:206, 1986 Miller R, Parry G, Lang W, Lippert R, Kiprov D. AIDS-related inflammatory Polyradiculoneuropathy: Prediction of response to plasma exchange with electrophysiologic testing. Muscle & Nerve Sept. p.6, 1985

The first description of an auto-immune hematologic syndrome in AIDS and its treatment with Protein A immunoadsorption.

Abrams D., Kiprov D, Volberding P. Isolated Thrombocytopenia in Homosexual Men- Longitudinal Follow-up, AIDS-associated Syndromes: Advances in Experimental Medicine and Biology 187: 117-122, 1985. Abrams D, Kiprov D, Geodert J, et al. Antibodies to Human T-Lymphotropic Virus Type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. Ann Intern Med 104:47-50, 1986. Mitterman A, Bertram D, Snyder H, Messerchmidt G, Diavarella D, Ainsworth S, Kiprov D, Arlin Z. Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba Column) Immunoadsorption. Seminars in Hematology, 1989, 26:15-18

Conducted experiments which suggested that alloimmunization may prevent AIDS.

Kiprov D, Hanson C, Sheppard H.: Alloimmunization to Prevent AIDS? Science, 11 February, 1994, vol. 263, p. 737

Published the most comprehensive study of adverse reactions of therapeutic apheresis.

Dobri D. Kiprov, Patricia Golden, Regina Rohe, Sheila Smith, Jan Hofmann, and John Hunnicrat. Adverse Reactions Associated With Mobile Therapeutic Apheresis: Analysis of 17,940 procedures. JClinApheresis 16:130-133, 2001

Other Publications

Kiprov D., Griffel, B. Inverted Meckel's Diverticulum, Arch Surg.110:1154, 1975

Kiprov D. Immunologically mediated glomular and tabular diseases. In: Harvard, Course of Immunology for Non-immunologists. Harvard University Press, Boston, 1980.

Kiprov D. Colvin R, McCluskey R. Focal segmental glomerulosclerosis in patients with unilateral renal agenesis. In: Proceedings of the 13th Annual Meeting, American Society of Nephrology, 1980. Abstract

. Kiprov D. Immunnologically mediated renal diseases. In: Harvard Course of Allergy and Clinical Immunology. Harvard University Press, Boston, 1981.

Asielo D, Kiprov D, Lithium Nephropathy. Case records of Massachusetts General Hospital. NEJM 304:1025, 1981

Kradin R, Kiprov D. Immune complex disease in a patient with myasthenia gravis. Arch Pathol 105:582, 1981.

Bernard D, Kiprov D. Acute renal failure in minimal change disease. Case records of Massachusetts General Hospital. NEJM 306:331, 1982

Kiprov D, Colvin R, McCluskey R. Focal and segmental glomerulosclerosis and proteinura associated with unilateral renal agenesis. Lab Invest 46:275, 1982.

Kiprov D, Dau P. The effect of plasmapheresis and immunosuppressive therapy on T-cell subsets as defined by monoclonal antibodies. Plasma Therapy 3:337, 1982.

Kiprov D, Morand P. Lymphocyte subpopulations and mitogenic response studies in homosexuals with acquired immunodeficiency syndrome. Immunobiology 163:377, 1982.

Kiprov D, Dau P, Morand P. The effect of plasmapheresis on cellular immunity in patients with immunogenic disorders. Immunobiology 163:377, 1982.

Kiprov D, Dau P, Morand P. The effect of plasmapheresis and immunosuppressive drug therapy on T-cell subsets as defined by monoclonal antibodies. J Clin Aphere 1-57, 1983.

Kiprov D, Influences of plasmapheresis on cellular immunity. In: Plasma Separation and Plasma Fractionation (Current Status and Future Directions) eds Lysaght MJ, Gurland HJ, Karger S, Basel AG, 1983.

Kiprov D, Busch D, Simpson D, et al. Antilymphocyte factors in the Acquired Immune Deficiency Syndrome. In: The Acquired Immune Deficiency Syndrome. Eds. Gottlieb, MS, Groopman JE, Liss AR, New York, pp. 299-301, 1984.

Kiprov D, Miller R. The use of plasmapheresis in the treatment of polymyositis like syndrome and peripheral neuropathies associated with monoclonal serum paraproteins. Artificial Organs 8(1):123, 1984.

Kiprov D, Busch D, Simpson D, et al. The role of apheresis procedures as an immunoregulatory therapy in AIDS related conditions. J Cell Biochem, Suppl 8A, p 22, 1984.

Kiprov D, Busch D, Simpson D, et al: Antilymphocyte serum factors in patients with AIDS. J Cell Biochem, Suppl 8A, p.15 (abstract) 1984

. Kiprov D, Miller R. Polymyositis associated with benign monoclonal gammopathy. Lancet II:1183-1186, 1984.

Kiprov D, Lippert R, Jones F, et al. Extracorporeal perfusion of plasma over Protein A in patients with AIDS related Kaposi’s Sarcoma. Ann de Medine Interne 135:12, 1984.

Kiprov D, Miller R, Lippert R. Polymyositis associated with monoclonal gammopathy. A new syndrome successfully treated with plasma exchange. Ann de Medicine Interne 135:18, 1984.

Kiprov D, Miller R. Paraproteinemia associated with demyelinating polyneuropathy or myositis: Treatment with plasmapheresis and immunosuppressive drugs. Artif Organs: 47-52, 1985

Kiprov D, An overview of therapeutic apheresis. Dial Transplantation 14:195-200, 1985

Simpkins H, Kiprov D, Davis BJ, et al. T-cell CLL with unusual immunologic phenotype and function. Blood 65:127-133, 1985.

Kiprov D, Anderson RE, Morand P, Simpson D, Chermann JC, Levy J, Moss A. Antilymphocyte antibodies and seroposivisity for retroviruses in high risk groups for AIDS. N Engl Med 312:1517, 1985.

Lipkin I, Parry G, Kiprov D, et al. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology 35:1479-1483, 1985.

Miller R, Parry G, Lang W, Lippert R, Kiprov D. AIDS-related Inflammatory Polyradiculoneuropathy: Prediction of response to plasma exchange with electrophysiologic testing. Muscle & Nerve Sept. p.6, 1985.

Kiprov D, Lippert R, Sandstrom E, et al. Acquired Immunodeficiency Syndrome (AIDS) – Longitudinal Follow-up. AIDS-associated Syndromes: Advances in Experimental Medicine and Biology 187:117-122, 1985.

Abrams D, Kiprov D, Volberding P. Isolated Thrombocytopenia in Homosexual Men – Longitudinal Follow-up, AIDS-Associated Syndromes: Advances in Experimental Medicine and Biology 187:117-122, 1985

Abrams D, Kiprov D, Geodert J, et al. Antibodies to Human T-Lymphotropic Virus Type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. Ann Intern Med 104:47-50, 1986.

Kiprov D, Lippert R, Miller R, et al. The use of plasmapheresis, lymphocytaphersis and staph protein A immunoadsorption as an immunomodulatory therapy in patients with AIDS and AIDS-related conditions. J Clin Apere 3:133-139, 1986

Pfaeffl W, Qwasmeh A, Kiprov D. Complement activation in apheresis procedures. In: Immune and Metabolic Aspects of Therapeutic Blood Purification Systems. Eds. Karger S, Basel AG, Trondheim, pp. 323-328, 1986.

Miller R, Parry G, Lang W, Lippert R, Kiprov D. AIDS-related inflammatory polyradiculoneuropathy: successful treatment with plasma exchange. Neurol 36:206, 1986

Kiprov D. Transmission of the human immunodeficiency virus (HIV) through plasma exchange procedures. ASFA Newsletter. 6(2):2, 1986.

Kiprov D, Simpson D, Pfaeffl W, Romanick-Schmiedl S, Abrams D, Miller R. AIDS and apheresis procedures – Therapeutic and safety considerations. Blood Purification. 5:51-56, 1987.

Kiprov D, Simpson D. Romanich-Schmiedl S, Lippert R, Spira T, Busch D, The risk of AIDS transmission through therapeutic apheresis. J Clin Apher 3:143-6, 1987.

Kiprov D, Romanick-Schmiedl S. The impact of AIDS epidemic on therapeutic hemapheresis. Plasma Ther Transfus Technol 8:23-29, 1987.

Kiprov D, Pfaeffl W, Parry G, Lang W, Miller R. Antibody-mediated peripheral neuropathies associated with ARC and AIDS: Successful treatment with plasmapheresis. J Clin Aphere 4:3-7, 1988.

Miller R, Kiprov D, Parry G, Bredesen DE. HIV related peripheral neuropathies in: The Nervous System, in AIDS Chapter 4. Eds. MI, Rosenbaum et al. Raven Press, New York, 1988.

Miller R, Parry G, Pfaeffl W, Lang W, Lippert R, Kiprov D. The spectrum of peripheral neuropathy associated with ARC and AIDS. Muscle and Nerve 11:857-863, 1988.

Kiprov D, Conant M, Lippert R, Pfaeffl W, Miller R, Abrams D. Therapeutic Apheresis as a Treatment Modality in AIDS and AIDS-Related Conditions. AIDS, Principles, Practices and Politics, Reference Addition, 9:113-117 (1988)

Kiprov D, Simpson D, Busch M. Hemapheresis and the acquired immunodeficiency syndrome. In Donor Hemapheresis, cd. Pineda A, Wichtig Editore, Milan, 1989, p. 135-140.

Mitterman A, Bertram D, Snyder H, Messerchmidt G, Diavarella D, Ainsworth S, Kiprov D, Arlin Z. Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba Column) Immunoadsorption. Seminars in Hematology, 1989, 26:15-18.

Messerschmidt D, Henery D, Snyder H, Bertman J, Mittleman A, Ainsworth S, Fiore J, Viola M, Louie J, Ambinder E, MacKintosh F, Higby D, O’Brien P, Kiprov D, Hamberger M, Balint J, Fiosher L, Perkins W, Pinsky C, Jones F. Protein A immunotherapy in the treatment of Cancer. An Update. Seminars in Hematology, Vol 26, No 2, Suppl 1 (April), 1989: pp 19-24.

Kiprov D, Kwiatkowska B, Miller R: Therapeutic apheresis in HIV-related syndromes, in: Therapeutic Hemapheresis in the 1990’s, ed. Nydeger, U, Curr Stud Nematol Blood Transus. Basel, Karger, 1990.

Kiprov D, Kwiatkowska B, Miller G, Plasmapheresis dans les syndromes assoicees a l’infection per HIV Medicine et Hygiene (Medet Hyg) 48:1454/8, 1990.

Kiprov D, Protein A Immunoadsorption: Immunomodulatory effects, Apheresis, ed. Rock G, Alan R, Liss, Inc, 1990, p. 449-452.

Romanick-Schmiedl S, Miller R, Kiprov D. Extraneurologic manifestations of chronic inflammatory demyelinating peripheral neuropathy – response to therapeutic plasmapheresis. Am J Med. 89:531-5343, 1990.

Stricker R, Kiprov D. Combined use of plasmapheresis and intravenous gammaglobulin in the treatment of HIV-positive and HIV-negative autoimmune syndromes. Immunotherapy with Intravenous immunoglobulins. Ed. Imback P. 1991,

Academic Press, London, San Diego.

Miller R, Kiprov D. Roan R, Repeat thymectomy in chronic refractory myasthenia gravis. Neurology, June 1991;41-923-924.

Snyder J, Bertman H, Henry D, Kiprov D. Use of protein A immunoadsorption as a treatment for thrombocytopenia in HIV-infected homosexual men: A retrospective evaluation of 37 cases. Ltd. AIDS 1991, 5:1257-1260.

Kiprov D. Editorial, Journal of Clinical Apheresis Volume 6-2 pp 92, 1991

. Penton R, MacLeod D, Stricker R, Kiprov D. Impact of the HIV epidemic on therapeutic apheresis: Nursing considerations. Journal of Clinical Apheresis 6:124-126 (1991)

. Kiprov D, Stricker R, Nachtigall R, Maine E, Smith S, Dumlao C, Jacobson A, Garovoy M, Levinson C. Intravenous gammaglobulin (IVIG) treatment of recurrent spontaneous abortion (RSA) associated with combined alloimmune and autoimmune abnormalities. J Immunol Immunopharmocology 1992; 12:108.

Stricker R, Main E, Kronfield J, Kallas G, Gerson L, Autry A, Kiprov D. Severe post partum eclampsia: Response to Plasma Exchange. Journal of Clinical Apheresis, 7:1-3 (1992)

Stricker R, Kiprov D. Pathogenetic considerations and prognostic factors in Thrombotic thrombocytopenic purpura (TTP). Journal of Clinical Apheresis, Volume 7:40-41 (1992).

Kiprov D, Stricker R, Nachtigall R, Main E, Smith S, Dumlao C, Jacobson A, Garovoy M, Levinson C. A controlled study of lymphocyte immunization in recurrent spontaneous abortion (RSA): The role of antilymphocyte antibodies (ALA). J Immunol Immunopharmocology 1992; 12:108.

Stricker R, Sanders KA, Owen MF, Kiprov D, Miller RG. Mononeuritis Multiplex associated with Cryoglobulinemia in HIV infection. Neurology, 1992; 42:2103-2105.

Stricker R, Davis A, Gyershow J, Yamamoto K, Kiprov D. Thrombotic Thrombocytopenic Purpura Complicating Systemic Lupus Erythematosus. Case Report and Literature Review from the Plasmapheresis Era. J Rheumatol 1992;19:1469-73.

Smith S, Smith J, Leiva J, Rohe-Penton R, Stricker R, Kiprov D. Quality Assurance and Improvement in Therapeutic Plasmapheresis – ACD Reactions in Patients with Myasthenia Gravis. Journal of Clinical Apheresis 1993, V 8 No. 1.

Stricker R, Kwiatkowska B, Habis J, MacLeod D, Kiprov D. Response to Plasmapheresis following Failure of Intravenous Gammaglobulin in Patients with Myasthenia Gravis and Guillain - Barre Syndrome. Journal of Clinical Apheresis 1993, V.8 No 1.

Sticker R, Minor R, Kiprov D. Thrombotic Microangiopathy Complicating Renal Carcinoma: Report of the First Two Cases. Journal of Clinical Apheresis 1993, V 8. No 1.

Kiprov D, New trends in immunotherapy – intravenous gammaglobulin (IVIG), J. Clinical Apheresis, 1993.

Strauss R, Ciavarella, D. Kiprov, D., et al. An Overview of Current Management, Journal of Clinical Apheresis, 8:189-194 (1993)

Kiprov, D, et al. Management of Autoimmune Disorders, Journal of Clinical Apheresis, 8:195-210 (1993)

McLeod D, Strauss R, Kiprov D., et al. Management of Hematological Disorders and Cancer, Journal of Clinical Apheresis 8:211-230 (1993)

Kasprisin D, Strauss R, Kiprov D., et al. Management of Metabolic and Miscellaneous Disorders, Journal of Clinical Apheresis 8:231-241 (1993)

Ciavarella D, Wuest D, Kiprov D., et al Management of Neurologic Disorders, Journal of Clinical Apheresis 8:242-257 (1993)

Gilcher R, Strauss R, Kiprov D, et al. Management of Renal Disorders, Journal of Clinical Apheresis 8:258-269 (1993)

Kiprov D, Stricker R, Treatment of HIV Neuropathy with Plasmapheresis and Intravenous Gammaglobulin – Therapeutic Plasmapheresis (XII), pp. 277-282. T. Agishi et al (Eds) VSP 1993

Stricker R, Kwiatkowska B, Kiprov D. Myasthenic Crisis Arch Neurol, Vol 50: 1:8, 1993

Kiprov D, Hanson C, Sheppard H.: Allogeneic Lymphocyte Antibodies: Protection from AIDS? Science, February, 1994

Kiprov D, Weckstein L, Jacobson A, Galen D, Weaver R. Intravenous Immunoglobulin for In-Vitro Fertilization Failure in Patients with Autoimmune Abnormalities. Am J Reprod Immune

Kiprov D, Rohe R, Smith S, Weaver R. Therapeutic Apheresis and Managed Care – Clinical Outcome versus Adverse Effects and Cost in 10,290 Procedures, J Clin Apheresis, 1996; 36:228-234.

Kiprov D. Quality Assurance and improvement Program in Therapeutic Apheresis (abstract), American Society for Apheresis Annual Meeting, St. Petersburg, Florida, May, 1998

Kiprov D, Golden P, Rohe R, et al. Adverse Reactions Associated with Therapeutic Apheresis – Analysis of 17,940 Procedures (abstract), American Society for Apheresis Annual Meeting, San Antonio, Texas, April, 1999

Hunnicutt J, Golden P, Kiprov D, et al. Hemolysis Due to Improper Dilution of 25% Albumin used in Plasmapheresis (abstract) American Society for Apheresis Annual Meeting, San Antonio, Texas, April, 1999

Kiprov D, Rohe R, The Use of Digital Versatile Disc (DVD) In Mobile Therapeutic Apheresis Services (abstract), American Society for Apheresis Annual Meeting, San Antonio, Texas, April, 1999

Hofmann J, Rohe R, Smith S, Kiprov D. Increasing Incidence of Thrombotic Thrombocytopenic Purpura (abstract), American Society for Apheresis Annual Meeting, Niagara Falls, New York, May, 2001

Kiprov D, Golden P, Rohe, R, Smith S, Hofmann J, et al. Adverse Reactions Associated with Mobile Therapeutic Apheresis: Analysis of 17,940 Procedures, J Clin Apheresis, 2001; 16:130-133.

Kiprov D, Hofmann J, Plasmapheresis in Immunologically Mediated Polyneuropathies. Therapeutic Apheresis and Dialysis 2003;7(2):189-196

Kiprov D, Rohe R, Hofmann, J. Exclusive Therapeutic Apheresis Delivery System. Transfusion and Apheresis Science, 2003:28:173-179.

Kiprov D, Theme Section: Therapeutic Apheresis Delivery Systems in the US; Guest Editorial, Transfusion and Apheresis Science, 2003:28:163-164.

Hofmann J, Reynolds, S, Kiprov, D. Demyelinating Polyneuropathy after Gastric Bypass Surgery: Response to Plasma Exchange, Journal of Clinical Apheresis 18:75-97 (2003)

Hofmann, J, Costello G, Kiprov, D. Postpartum TTP-HUS: Better Response to early Plasma Exchange. Journal of Clinical Apheresis 18:9-10 (2005)

Hofmann J, Smith S, Rohe R, Kiprov, D. Severe Plasmodium Falciparum Malaria: Utility of RBC Exchange Transfusion. Journal of Clinical Apheresis 18:24 (2005)

Hofmann J, Reynolds, S, Kiprov, D. Nephrogenic Fibrosing Dermopathy: Response to Plasma Exchange. Journal of Clinical Apheresis 18:12-13 (2005)

Kiprov, D. Delivery of Therapeutic Apheresis Services in the United States. Journal of Clinical Apheresis 20:123-125 (2005)

Hofmann J, Smith S, Kiprov D. Autoimmune Retinopathy: Treatment with Plasma Exchange and/or Intravenous Immunoglobulin. Journal of Clinical Apheresis 21:20-21 (2006)

Hofmann J, Kiprov D. Acute Humoral Renal Transplant Rejection: Successful Rescue T herapy with Plasmapheresis with or without Intravenous Immunoglobulin. Journal of Clinical Apheresis 21:34-35 (2006)

Hofmann, J, Kiprov, D. Hepatitis C Associated Cryoglobulinemia: Successful Response to Plasma Exchange. Journal of Clinical Apheresis 22:65 (2007)

Hofmann, J, Kiprov D. Gemcitabine Associated TTP-HUS: Response to Plasmapheresis. Journal of Clinical Apheresis 22:84-85 (2007).

Hofmann J, Weisshaar D, Pham M, Kiprov D. “Antibody mediated cardiac transplant rejection: successful graft rescue with immunotherapy.” J Clin Apheresis 2008; 23 (1): 9-10.

Hofmann J, Kiprov D. “Sunitinib associated thrombotic microangiopathy in a patient with renal cell carcinoma: a new cause of TTP-HUS?” J Clin Apheresis 2008; 23 (1): 42.

Hofmann J, Warvariv V, Kiprov D. “Successful allograft salvage with immunotherapy in acute humoral renal transplant rejection.” J Clin Apheresis 2008; 23 (1): 15-16.

Hofmann JC, Smith SJ, Kiprov DD. “Leukocytapheresis Treatment for Patients with Acute Leukemia and Blast Crisis Enables a High Percentage of Patients to Undergo Induction Chemotherapy.” J Clin Apheresis 2010; 25 (1): 4-5.

Kiprov, D, “Intermittent Heterochronic Plasma Exchange as a Modality for Delaying Cellular Senescence – A Hypothesis.” J Clin Apheresis 28:387-389 (2013).

Kiprov D, Burgstaler E, Sanchez A, “Apheresis Instrumentation”. ASFA Principles of Apheresis Technology, Fifth Edition 2:23-41 (2014). Kiprov D, Sanchez A, Pusey C, “Therapeutic Apheresis.” Handbook of Dialysis, fifth edition, 18:333 (2015).

Hofmann JC, Kiprov DD. “Uncovering complement-mediated thrombotic microangiopathy in the setting of sepsis, colitis, and progressive renal failure”. (Abstract) Ther Apher Dial 2015; 19 (2): 101-102.

Hofmann JC, Kiprov DD, Lewis BH. “Uncovering complement-mediated thrombotic microangiopathy in the setting of a second pregnancy and prior pre- eclampsia: A real-time exercise in “ruling-in” atypical hemolytic uremic syndrome”. (Abstract) J Clin Apher 2015; 30 (1): 99-100.

Hofmann JC, Kiprov DD, Lewis BH. “Utility of a novel genetic assay to confirm the diagnosis of complement-mediated thrombotic microangiopathy”. (Abstract) Transfusion 2016; 56; suppl. S4: 275A.

Hofmann JC, Kiprov DD. “Therapeutic plasma exchange in patients with hypertriglyceridemic pancreatitis: When is it indicated?” (Abstract) J Clin Apher 2016; 31 (1): 103-104.

Hofmann JC, Kiprov DD. “Plasma exchange may not always be necessary in patients with hypertriglyceridemia and acute pancreatitis”. (Abstract) Transfusion 2017; 57; suppl. S3: 99A.

Hofmann JC, Kiprov DD. “Cytoreductive therapy for cellular hyperviscosity: Utility of cytapheresis treatment for chronic myelogenous leukemia and essential thrombocythemia”. (Abstract) Transfusion 2017; 57; suppl. S3: 49A-50A.

Hofmann JC, Kiprov DD. “Therapeutic plasma exchange in patients with acute transverse myelitis: Is it efficacious?” (Abstract) J Clin Apher 2017; 32 (2): 112.

Hofmann JC, Kiprov DD. "Antibody-mediated diffuse alveolar hemorrhage in pulmonary-renal vasculitides: enhanced resolution with emergent adjunctive plasma exchange". Transfusion 2018; 58 (suppl. S2): 96A.

Hofmann JD, Kiprov DD. "Utility of therapeutic plasma exchange in the treatment of catastrophic antiphospholipid syndrome: a 15-year retrospective review". Apher Transfus Sci 2019; 33 (2):

Melod Mehdipour, Colin Skinner, Nathan Wong, Michael Lieb, Chao Liu, Jessy Etienne, Cameron Kato, Dobri Kiprov, Michael J. Conboy, Irina M. Conboy, Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin. Aging (Albany. NY). 12, 8790–8819 (2020). Kiprov, D., Conboy, M. J. & Conboy, I. M. Immunomodulation for the management of corona virus disease (COVID-19). Transfus. Apher. Sci. 59, 102856 (2020).